Placebo-Controlled Evaluation of the Efficacy and Tolerability of Permixon® in Benign Prostatic Hyperplasia after Exclusion of Placebo Responders
- 1 May 1995
- journal article
- Published by Springer Nature in Clinical Drug Investigation
- Vol. 9 (5) , 291-297
- https://doi.org/10.2165/00044011-199509050-00007
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: